Inhibition by 4-aminopyridine of HERG K+ channels expressed in a mammalian cell line

University of Leeds (2002) J Physiol 544P, S135

Communications: Inhibition by 4-aminopyridine of HERG K+ channels expressed in a mammalian cell line

John M. Ridley, James T. Milnes, Harry J. Witchel and Jules C. Hancox

Department of Physiology and Cardiovascular Research Laboratories, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK

View other abstracts by:


4-Aminopyridine (4-AP) is used extensively in the field of cardiac muscle electrophysiology to study the role (s) in cardiac tissue of transient outward K+ current (Ito). Although millimolar 4-AP is widely considered to be selective for Ito, results of a previous study from this laboratory suggested that 4-AP might, in addition, exert an inhibitory effect on the rapid delayed rectifier K+ current, IKr (Mitcheson & Hancox, 1999). The aim of the present study was to investigate further this possibility, by characterising effects of 4-AP on heterologously expressed HERG channels, since HERG (human-ether-a-go-go-related gene) encodes the pore-forming subunit of channels responsible for IKr (Sanguinetti & Keating, 1997).

Measurements of whole-cell HERG current (IHERG) were made at 37 ± 1 °C from a mammalian cell line (HEK-293) stably expressing HERG (Zhou et al. 1998). IHERG ‘tail’ amplitude was monitored at -40 mV, following activating pulses to +30 mV. 4-AP was found to exert a concentration-dependent inhibitory effect on IHERG, with a half-maximal inhibitory concentration (IC50) of 4.4 ± 0.5 mM (mean ± S.E.M.; n = minimum of 5 cells for each of seven 4-AP concentrations between 0.1 and 100 mM). Positive control experiments under similar conditions with the methanesulphonanilide HERG blocker E-4031 gave an IC50 value near to 12 nM, which is close to an IC50 value (7.7 nM) observed previously for E-4031 with this cell line (Zhou et al. 1998). Inhibition of IHERG by 5 mM 4-AP was observed to be voltage dependent; 4-AP also shifted voltage-dependent activation of IHERG towards more negative voltages, producing a mean shift in half-maximal activation of -7.4 ± 0.9 mV (n = 8 cells). In experiments utilising a ventricular AP waveform as the voltage command, 5 mM 4-AP suppressed the peak outward IHERG elicited during the AP repolarisation phase by 58.5 ± 4.1 % (n = 5 cells).

We conclude that 4-AP is a low-affinity blocker of cardiac HERG potassium channels, blocking IHERG with a potency similar to that suggested for IKr from previous experiments on rabbit native cardiomyocytes (Mitcheson & Hancox, 1999). Since 4-AP concentrations in the millimolar range are used in investigations of cardiac Ito, our results confirm that an accessory inhibitory effect on IKr may need to be taken into account in interpreting data that might otherwise be ascribed to selective inhibition of Ito.

This work was supported by the British Heart Foundation and The Wellcome Trust.

3




Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type